关键词 Duchenne 型肌营养不良症; 活动; 评估; 信度; 效度ReliabilityandvalidityoftheChineseversionofNorthStarAmbulatoryAssessmentforchildrenwithDuchennemusculardystrophySHIWei1,3),LIHui1,3),LIXi⁃huan2),SUYi1),ZHAOLei2),LUKai1),HUXiao⁃ping2),ZHAIChun1),ZHOUShui⁃zhen2)(Children'sHospitalofFudan...
运动功能评估目的:通过分析Duchenne型肌营养不良(Duchenne muscular dystrophy,DMD)患者骨盆及大腿肌肉T2 mapping成像结果,探讨T2值与临床运动功能的相关性.方法对12名DMD患者进行临床运动功能评估(9 m步行时间,四阶梯时间,卧立位时间)和T2 mapping成像研究.通过Pearson相关和Spearman秩相关分析骨盆和大腿15块肌肉T2值与...
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads to difficulties with movement and, eventually, to the need for assisted ventilation and premature death. The disease is caused by mutations in DMD (encoding dystrophi
Duchenne型肌营养不良(Duchenne muscular dystrophy, DMD)是由抗肌萎缩蛋白基因的致病性变异所致的一种X连锁隐性遗传性肌病,属于罕见病,在存活男婴中的发病率约为1/5000[1]。DMD患者主要表现为四肢近端及躯干肌的进行性无力,一般在3—4岁...
REGENXBIO expects to make a pivotal dose determination in mid-2024. The Company also expects to share strength and functional assessment data for both dose levels and the initiation of a pivotal trial in the second half of 2024. The Company plans to use RGX-202 microdystrophin expression as ...
Duvyzat (givinostat), an oral therapy approved for Duchenne muscular dystrophy (DMD) patients ages 6 and older, works to reduce inflammation.
目的了解北极星移动评价量表(North Star Ambulatory Assessment,NSAA)应用在Duchenne型肌营养不良(Duchenne muscular dystrophy,DMD)患儿中的组间信度及组内信度,并探讨通过录像法评测运动功能的可行性.方法分析2017年7月至2017年11月北京大学第一医院使用NSAA对40例DMD患儿进行运动功能评估的资料.40例DMD患儿年龄4.3~13.4...
Reliability and validity of the Chinese version of North Star Ambulatory Assessment for children with Duchenne muscular dystrophy SHI Wei]'3)，LI Hui1' 3)，LI Xi-huan2)，SU Yi!)，ZHAO Lei2)，LU Kai!)，HU Xiao-ping2)，ZHAI Chun1]，ZHOU Shui-zhen2)(Children's Hospital of Fudan ...
Geographical distribution of the Duchenne muscular dystrophy epidemiological studies included in the systematic review Full size image Quality of study reporting assessment Overall, the quality of 44 studies was evaluated. In total 36 (81.8%) studies were assessed as being of medium and 8 (18.2%) ...
dystrophy.Front Cardiovasc Med2017;4:82. doi: 10.3389/fcvm.2017.00082.6.JH Soslow, M Xu, JC Slaughter, M Stanley, K Crum, LW Markham. Evaluation of echocardiographic measures of left ventricular function in patients with...